Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly

NCT07208630 — Not applicable, Recruiting, 60 participants, Cairo University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07208630, acronym IASTM-AGE
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment60 (Estimated)
SponsorCairo University (Other)
ConditionsFunctional Abilities, Cognitive Abilities
InterventionsInstrument-assisted soft tissue mobilization, Traditional physical therapy (Device, behavioral)
Datesstart 2025-10-03, primary completion 2026-03-01 (estimated), completion 2026-03-01 (estimated), first posted 2025-10-06, last updated 2026-02-24
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Functional Abilities All trials for Cognitive Abilities All trials of Instrument-assisted soft tissue mobilization All trials of Traditional physical therapy

-Summary

PURPOSE: To determine the effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly.

BACKGROUND: There is an increased interest in health care with growth of the older population.

Instrument-Assisted Soft Tissue Mobilization (IASTM) is a manual therapy technique using specially designed tools to apply pressure and mobilize soft tissues. It has gained attention as a non-invasive intervention that can aid in improving musculoskeletal health and overall function, especially in older adults. Given the aging population and the rise in age-related functional and cognitive decline, there is a pressing need for effective strategies to enhance quality of life in this demographic.

In the elderly, musculoskeletal issues, such as reduced muscle flexibility, joint stiffness, and soft tissue restrictions, are common and can severely impact physical function. IASTM has been shown to increase tissue perfusion, reduce fascial restrictions, and improve joint mobility. These effects are critical in countering age-related declines in mobility, balance, and overall physical functionality, ultimately promoting greater independence and reducing fall risk. Improved physical function through IASTM may also influence cognitive health positively, as increased physical activity and mobility are linked to better cognitive outcomes in the elderly.

HYPOTHESES: There will be no significant effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly.

RESEARCH QUESTION: Does instrument-assisted soft tissue mobilization is effective on functional and cognitive abilities in elderly?

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
IASTM on calf muscle bilaterally plus conventional treatment (strengthening and stretching exerciseExperimentalDevice: Instrument-assisted soft tissue mobilization; Behavioral: Traditional physical therapy
control group, will receive conventional treatmentActive comparatorBehavioral: Traditional physical therapy
  • Instrument-assisted soft tissue mobilization (Device): IASTM will be delivered using stainless-steel instruments with beveled edges, applied to the target muscle groups for approximately 20 minutes per session, two times per week, over four weeks. A licensed physical therapist trained in IASTM will perform the procedure. Lubricant will be applied to the skin, and strokes will be delivered in multiple directions with pressure adapted to patient tolerance.
  • Traditional physical therapy (Behavioral): The control group will receive a traditional physical therapy program focusing on strength, balance, flexibility, and functional mobility training, combined with simple cognitive stimulation tasks. Sessions will last 30 minutes, two times per week, for four weeks, supervised by a licensed physical therapist.

+Outcome measures

Primary outcomes

  • Change in Short Physical Performance Battery (SPPB) score [Baseline and 4 weeks (end of treatment).]: Mean change in SPPB total score (0-12; higher = better physical function) from baseline to end of intervention. The SPPB includes standing balance, 4-m gait speed, and five-times-sit-to-stand.

Secondary outcomes

  • Change in Montreal Cognitive Assessment (MoCA) score [Baseline and 4 weeks (end of treatment).]: Mean change in MoCA total score (0-30; higher = better cognition) from baseline to end of intervention and at follow-up.

+Eligibility

Sex: All, ages: 65 Years to 75 Years, accepts healthy volunteers

Inclusion Criteria:

* 60 elderly subjects aged range from 65-75 years old will participant in the study from both genders.
* had cognitive abilities to understand explanations and instructions
* did not take any medication that can affect their balance.

Exclusion Criteria:

* They neither had sever musculoskeletal disorders
* Nor neurological damage related to balance (dizziness, vestibular dysfunction)
* Nor orthostatic hypotension
* Nor health risk factors.

+Locations (1)

FacilityCityCountryStatus
Faculty of physical therapyGizaEgyptRecruiting